News
New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria ...
So here's the thing about type 2 diabetes: everybody makes it sound like once you get it, that’s it. Lifetime of meds, check ...
New research (the Ver-A-T1D trial) presented at the Annual Meeting of the European Association for the Study of Diabetes ...
In ELSA, children were offered islet autoantibody screening via DBS collection in schools, primary-care clinics, and more.
Analysis by researchers at the University of Bern suggests that water and other volatile compounds arrived on Earth from ...
News-Medical.Net on MSN
Verapamil shows potential for preserving beta-cell function in type 1 diabetes
New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of ...
News-Medical.Net on MSN
New findings support low-dose ATG to delay progression of type 1 diabetes
New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, ...
Individuals with MASLD have a higher rate of appearance of oral glucose after glucose overload — indicating greater intestinal glucose absorption — than those without the condition, a study finds.
New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September ...
A NEW test that can help predict how people will respond to weight loss medications, such as weight loss jabs, has been ...
The Health Benefits of Drinking Kombucha Kombucha is bubbly fermented tea that’s perhaps most widely known for its probiotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results